Biotech

All Articles

Lykos will definitely ask FDA to reconsider its decision following rejection of MDMA treatment for post-traumatic stress disorder

.Complying with a bad revealing for Lykos Therapeutics' MDMA prospect for trauma at a recent FDA adv...

AN 2 fifty percents head count, stops period 3 test after records let down

.AN2 Therapies is reviewing its own service in response to uninspired midphase data, swearing to giv...

Merck pays out $700M for bispecific, spying autoimmune opening and chance to test Amgen in cancer

.Merck &amp Co. is actually paying for $700 thousand beforehand to test Amgen in a blood stream canc...

Gilead pays out J&ampJ $320M to go out licensing offer for seladelpar

.With Gilead Sciences almost an FDA selection for its liver disease medicine seladelpar, the firm ha...

' All hands on deck' at Lilly as peers target being overweight market

.CEO David Ricks may observe the companies setting up tents at basecamp responsible for Eli Lilly in...

Entero laying off team, vacating workplace and stopping R&ampD

.Mattress Liquidators has actually transformed Entero Therapeutics white colored as a sheet. The cre...

Exelixis loses ADC after deciding it's no match for Tivdak

.Exelixis is actually quiting on its tissue element (TF)- targeting antibody-drug conjugate after wr...

Relay dislikes SHP2 prevention after Genentech leaves

.Three weeks after Roche's Genentech system ignored an SHP2 prevention contract, Relay Therapeutics ...

Stoke's Dravet disorder med launched of partial clinical hold

.Stoke Therapeutics' Dravet disorder drug has been actually devoid of a predisposed grip, removing t...

Fierce Biotech's Gabrielle Masson offers Intense 15 at NYSE

.Strong Biotech Colleague Publisher Gabrielle Masson provided the 2024 lesson of Strong 15 victors o...